Current approaches to the management of smoking cessation

Drugs

Volumn 62, Issue SUPPL. 2, 2002, Pages 53-61

  Sutherland, Gay ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETATE SILVER; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BUSPIRONE; CLONIDINE; DOXEPIN; FLUOXETINE; GLUCOSE; LOBELINE; MECAMYLAMINE; MOCLOBEMIDE; NALOXONE; NALTREXONE; NICOTINE; OPIATE ANTAGONIST; SILVER DERIVATIVE; UNCLASSIFIED DRUG;

ANXIETY NEUROSIS; BEHAVIOR THERAPY; DROWSINESS; DRUG CHOICE; DRUG EFFICACY; FATIGUE; HEADACHE; HUMAN; INSOMNIA; MORBIDITY; MORTALITY; PATIENT ATTITUDE; PATIENT COUNSELING; PATIENT SELECTION; PRACTICE GUIDELINE; RASH; REVIEW; SMOKING CESSATION; SUSTAINED RELEASE PREPARATION; TOBACCO DEPENDENCE; TREATMENT INDICATION; XEROSTOMIA;

NICOTIANA TABACUM;

EID: 0036312722     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200262002-00006     Document Type: Review

References (92)

1. Motivation for smoking cessation: What role do doctors play?
2. Treatment of tobacco use and dependence
3. Smoking cessation guidelines for health professionals: A guide to effective smoking cessation interventions for the healthcare system
4. Does over-the-counter nicotine replacement therapy improve smokers' life expectancy?
5. Smoking and health: Physician responsibility
6. Place of bupropion in smoking cessation therapy
7. Smoking cessation among self-quitters
8. Smoking cessation
9. Smoking cessation guidelines for health professionals: An update
10. Cigarette smoking: The clinician's role in cessation, prevention, and public health
11. Effects of general practitioners' advice against smoking
12. Smoking cessation and tobacco control: An overview
13. Smoking status as a new vital sign: Effects on assessment and intervention in patients who smoke
14. Smoking cessation: Integrating recent advances into clinical practice
15. Effectiveness of interventions to help people stop smoking: Findings from the Cochrane Library
16. Physician advice for smoking cessation
17. Nursing interventions for smoking cessation
18. Qualitative study of patients' perception of doctors advice to quit smoking: Implications for opportunistic health promotion
19. New developments in smoking cessation
20. Managing smoking cessation: Implementing new guidelines in primary care presents a challenge
21. Smoking cessation: Principles and practice based upon the AHCPR Guidelines, 1996
22. General practitioners' views on the provision of nicotine replacement therapy and bupropion
23. Individual bebavioural counselling for smoking cessation
24. Group behaviour therapy programmes for smoking cessation
25. A clinical practice guideline for treating tobacco use and dependence. A US Public Health Service Report
26. Smoking cessation: Evidence based recommendations for healthcare systems
27. Self-help interventions for smoking cessation
28. Smoking cessation: The contribution of community pharmacy
29. The virtual visit: Using telecommunications technology to take care of patients
30. Effectiveness of antismoking telephone helpline: Follow up survey
31. The effectiveness of callback counselling for smoking cessation: A randomized trial
32. Adding behavioral therapy to medication for smoking cessation
33. Smoking cessation strategies for the 21st century
34. Cost effectiveness of computer tailored and non-tailored smoking cessation letters in general practice: Randomised controlled trial
35. Exercise effects on withdrawal and mood among women attempting smoking cessation
36. Does exercise aid smoking cessation?: A systematic review
37. A meta-analysis of acupuncture techniques for smoking cessation
38. Pharmacotherapy of smoking cessation
39. Tobacco dependence: Global public health potential for new medications development and indications
40. Nicotine replacement therapy for smoking cessation
41. Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: A randomized, double-blind, placebo-controlled trial
42. Recent advances in the pharmacotherapy of smoking
43. Effectiveness of a transdermal nicotine system in smoking cessation studies
44. Smoking reduction with oral nicotine inhalers: Double blind, randomised clinical trial of efficacy and safety
45. The effectiveness of the nicotine patch for smoking cessation: A meta-analysis
46. Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation
47. Efficacy of a nicotine inhaler in smoking cessation: A double-blind, placebo-controlled trial
48. Guidance on the use of nicotine replacement therapy (NRT) and bupropion for smoking cessation
49. Effects of transdermal nicotine delivery as an adjunct to low intervention smoking cessation therapy: A randomized, placebo-controlled, double-blind study
50. Nicotine Gum, 2 and 4mg, for nicotine dependence: A double-blind placebo-controlled trial within a behavior modification support program
51. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up: One-year outcome and percentage of nicotine replacement
52. Bupropion: A new treatment for smokers. Nicotine replacement treatment should also be available on the NHS
53. Nicotine nasal spray with nicotine patch for smoking cessation: Randomized trial with six year follow up
54. Combined use of nicotine patch and gum in smoking cessation: A placebo-controlled clinical trial
55. Depression and the dynamics of smoking
56. Nicotine withdrawal symptoms and psychiatric disorders: Findings from an epidemiologic study of young adults
57. Nicotine dependence and major depression: New evidence from a prospective investigation
58. Non-nicotine pharmacotherapy for smoking cessation. Mechanisms and prospects
59. General psychiatry
60. Antidepressants and smoking cessation
61. A comparison of sustained-release bupropion and placebo for smoking cessation
62. Advances in non-nicotine pharmacotherapy for smoking cessation
63. Efficacy of bupropion for smoking cessation in non-depressed smokers
64. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
65. Antidepressants for smoking cessation
66. A meta-analysis of clinical studies confirms the effectiveness of bupropion SR (Zyban™) in smoking cessation
67. Sustained-release bupropion for pharmacological relapse prevention after smoking cessation: A randomized, controlled trial
68. A preliminary study of bupropion sustained-release for smoking cessation in patients with chronic posttraumatic stress disorder
69. Smoking cessation in patients with chronic obstructive pulmonary disease: A double-blind, placebo-controlled, randomised trial
70. Newly available treatments for nicotine addiction: Smokers wanting help to stop smoking now have effective treatment options
71. Bupropion: A review of its mechanism of antidepressant activity
72. Bupropion: A review of its use in the management of smoking cessation
73. Nicotine-mecamylamine treatment for smoking cessation: The role of pre-cessation therapy
74. Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone
75. Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers
76. Heavy smokers, smoking cessation, and clonidine: Results of a double-blind, randomized trial
77. Randomized, controlled trial of transdermal clonidine for smoking cessation
78. Naltrexone, smoking behaviour and cigarette withdrawal
79. A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse
80. Effects of a 2.5-mg silver acetate lozenge on initial and long-term smoking cessation
81. Double-blind placebo controlled trial of dextrose tablets and nicotine patch in smoking cessation
82. Acute effect of glucose tablets on desire to smoke
83. Glucose for smoking cessation: Does it have a role?
84. Potential benefits, limitations, and harms of clinical guidelines
85. Use of systematic reviews in clinical practice guidelines: Case study of smoking cessation
86. Treating tobacco use and dependence: An evidence-based clinical practice guideline for tobacco cessation
87. Effectiveness of smoking cessation initiatives